NPPB and Hyponatremia: In this review, we discuss the pathophysiologic mechanisms that increase total body Na and water, the induction of hyponatremia, how hyponatremia contributes to short-term and long-term outcomes in CHF and therapy with AVP V2 receptor antagonist, and a newly identified natriuretic protein.